Aberdeen Group’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.1M Sell
210,154
-11,523
-5% -$2.58M 0.08% 221
2025
Q4
$47.3M Buy
221,677
+172,251
+349% +$35.6M 0.07% 222
2025
Q3
$9.83M Sell
49,426
-90,180
-65% -$16.8M 0.02% 609
2025
Q2
$24.1M Sell
139,606
-32,125
-19% -$5.23M 0.04% 357
2025
Q1
$26.8M Sell
171,731
-15,449
-8% -$2.21M 0.05% 314
2024
Q4
$25.8M Buy
187,180
+28,967
+18% +$3.81M 0.05% 318
2024
Q3
$23.6M Sell
158,213
-2,389
-1% -$323K 0.04% 351
2024
Q2
$21.9M Buy
160,602
+21,811
+16% +$2.97M 0.04% 362
2024
Q1
$21M Hold
138,791
0.04% 396
2023
Q4
$17.5M Buy
+138,791
New +$13.8M 0.04% 421

Other funds holding ASND